InvestorsHub Logo
Followers 98
Posts 11521
Boards Moderated 0
Alias Born 05/29/2014

Re: Luckyus post# 31742

Monday, 01/13/2020 9:48:29 PM

Monday, January 13, 2020 9:48:29 PM

Post# of 52110
GCAN has licensed their technology to symtomax. That’s it. GCAN clearly hit a home run with Symtomax. Looks like they are having this go to market now.

I wish I could buy shares of symtomax. Because I would buy as much as I could. At least they update their status on what appears to be a weekly basis.

GCAN likely gets a certain percentage for every tab made so that translates to revenues every quarter from here on out.

Who else will choose the GCAN technology for their company? What big fish are waiting in the pond? What other technologies will GCAN announce?

I hope they sell billions upon billions of these patches.

"Patience is bitter, but its fruit is sweet."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GCAN News